Get this report today!
Table of Contents
Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
*For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume. All currency conversions were calculated at constant average annual 2011 exchange rates.
*The French generics market had total revenues of $4,268.3 million in 2011, representing a compound annual growth rate (CAGR) of 7.6% between 2007 and 2011.
*Market consumption volumes increased with a CAGR of 15.7% between 2007 and 2011, to reach 44.8% of total pharma market volume in 2011.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 3% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $4,949.6 million by the end of 2016.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in France
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts
Macroeconomic indicators provide insight into general trends within the France economy
Key Questions Answered
What was the size of the France generics market by value in 2011?
What will be the size of the France generics market in 2016?
What factors are affecting the strength of competition in the France generics market?
How has the market performed over the last five years?
Talk to Robyn
00 1 718 213 49 04
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 Summary GlobalData's "PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013" report, provides ...
Introduction What are the implications for regulators, biosimilar companies and branded manufacturers? There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway ...
This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals. Using the unique Plimsoll method of analysis, each of the largest 198 companies is individually assessed and ranked ...
... Hale & tempest how to provide affordable medicines in today S competitive global market dr. Brian w tempest www.Briantempest.Com world generic medicines congress london ...
Reportlinker.com © Copyright 2013. All rights reserved.